key: cord-0917653-d5xs1mpd authors: AlAli, S. Y.; Abdulrahman, A.; Yaghi, O.; Janahi, E.; AlQahtani, M. title: SARS-Cov-2 Viral Load as an Indicator for COVID-19 Patients Hospital Stay date: 2020-11-06 journal: nan DOI: 10.1101/2020.11.04.20226365 sha: 955ee2219476a488301205d7686497cd0f486876 doc_id: 917653 cord_uid: d5xs1mpd Background/objective: The novel coronavirus disease 2019 (COVID-19) pandemic poses a global threat to the public health. There is a challenge in measuring the patients length of hospital stay and managing the healthcare resources to handle the situation successfully. Our objective is to use the qPCR cycle of threshold (Ct) as a tool in evaluating the severity of the infection and hence the length of hospital stay to better utilize and manage the healthcare resources. Methods: This cross sectional study was carried out on 306 patients who admitted to COVID-19 care centers in Kingdom of Bahrain from 20th March 2020 to 5th April 2020. Standard qPCR was used to estimate the viral load and data were analyzed to investigate the relationship between Ct values and various variables. Results: Out of 306 patients, 2 deaths, 1 active stable case and 303 recovered cases were reported. Ct value was significantly and negatively associated (P value <0.001) with length of hospital stay. The viral clearance was also inversely associated with the Ct values. Conclusion: Ct value was inversely associated with hospital stay duration (and time to viral clearance), higher the Ct value is indicative of faster time to viral clearance. This association could help to better manage the infection and resources allocation. Email: mqahtani@rcsi-mub.com CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.04.20226365 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 6, 2020. Coronavirus disease 2019 is caused by the newly identified strain of the 53 Coronavirus family Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 1 . Whilst 54 some patients may have mild symptoms, others develop a severe respiratory distress syndrome 55 with features of a blood coagulopathy requiring intensive support 2 . As a result, COVID-19 has 56 rapidly evolved into a pandemic that has put a severe burden on the healthcare services of some 57 countries, notably beds for both hospitalization and intensive care facilities 3 . Testing aids case 58 identification, case isolation and contact tracing, all of which are vital to limit coronavirus spread Threshold (Ct-Value) that has been suggested as a quantitative test to indirectly assess the viral 62 load 6 with severe cases having a much higher viral load than mild cases 7 . Therefore, the aim of 63 this study was to measure the viral load determined by the Ct value and relate that to viral 64 clearance to determine if this could predict length of hospital stay, as that may help guide 65 healthcare resource allocation. A cross sectional study was undertaken on 306 patients who were admitted to COVID-19 care negative, the test is repeated after 24 hours to confirm viral clearance, following which the 77 patients are discharged. Therefore, the length of stay was the same as the time to viral clearance 78 and the minimum stay of patients is four days. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.04.20226365 doi: medRxiv preprint 4 The diagnostic test used for SARS-CoV-2 was performed using qPCR on nasopharyngeal and 82 oropharyngeal samples. The samples were transferred to a viral transport media immediately 83 after collection and transported to a COVID-19 laboratory for testing. Diagnosed cases were a 84 heterogeneous sample of tested patients, they included symptomatic and asymptomatic 85 individuals with recent exposure to a confirmed COVID19 case or travelers arriving from high 86 risk countries. PCR test was conducted using Thermo Fisher Scientific (Waltham, MA) TaqPath RealTime PCR Instrument. The assay used followed the WHO protocol from Charité Virology, 89 Berlin, Germany 8 . and targeted the E gene. If the E gene was detected, the sample was then 90 confirmed by RdRP and N genes. The E gene CT value was reported and used in this study. CT Values >40 were considered negative. Positive and negative controls were included for quality 92 control purposes. Linear range was determined using serial log10 dilutions of standard RNA and was established 95 between 3·5 x 10 3 to 3·5 x 10 12 copies of RNA/mL, with amplification efficiency of 87% and 96 with a regression R 2 value higher than 0.99. The protocol and manuscript for this study were reviewed and approved by the National COVID-107 19 Research and Ethics Committee in Bahrain (Approval code: CRT-COVID2020-004). This 108 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. Of the 306 patients, there were 303 who had recovered, whilst 2 deaths and 1 active stable case 117 were excluded from the analysis. The descriptive summary of the patients is shown in Table 1 The regression analysis for Length of Stay using Ct value as a covariate is shown in Table 2 . Analysis on symptomatic individuals showed that symptomatic individuals have a lower mean Ct 136 value when compared to asymptomatic individuals. Asymptomatic individuals had a mean Ct 137 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.04.20226365 doi: medRxiv preprint 6 value of 27.8. Symptomatic individuals had a mean Ct value of 25.5. A Two sample T-test 138 showed a difference of 2.58 units in the mean Ct value between symptomatic and asymptomatic 139 patients (Table 3) . This study has shown that the higher the Ct values, the more rapid the viral clearance, leading to are not infectious and can be discharged from hospitals or care centers 11 . Bahrain has pursued a comprehensive testing program with all travelers arriving in the country 162 being tested, mobile screening services, random screening in high risk communities and 163 extensive contact tracing. This strategy has resulted in detecting many asymptomatic patients, in 164 contrast to other countries where the response has been directed solely towards symptomatic 165 patients, and has generated data that is critical for production of accurate prediction models 12 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10. 1101 Limitations of this study include that it was cross sectional and that the number of symptomatic 167 cases were few in number. The number of patients with multiple comorbidities were few and 168 therefore a model to take into account the protective effect of a high Ct value could not be 169 determined. In this current study it was evident that Ct value can predict the duration of hospital stay of 172 COVID-19 infected patients, which also suggests that viral clearance will be faster in higher Ct Ethics approval and consent to participate: The study was approved by the National Research and Ethics Committee. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 8 Consent for publication: Consent for publication was waived by the Ethical committee. Availability of data and materials: All the data for this study will be made available upon 193 reasonable request to the corresponding author. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.04.20226365 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.04.20226365 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.04.20226365 doi: medRxiv preprint 13 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted November 6, 2020. ; https://doi.org/10. 1101 The epidemiology and pathogenesis of coronavirus disease 204 (COVID-19) outbreak COVID-19 Coagulopathy in Caucasian 207 patients Hospital surge capacity in a tertiary emergency 209 referral centre during the COVID-19 outbreak in Italy Feasibility of controlling COVID-19 outbreaks by 212 isolation of cases and contacts. The Lancet Global health Diagnosing COVID-19: The Disease 215 and Tools for Detection SARS-CoV-2 Viral Load in Upper Respiratory 218 Specimens of Infected Patients. The New England journal of medicine Viral dynamics in mild and severe cases of COVID-19 The Lancet Infectious diseases Detection of 2019 novel coronavirus (2019-223 nCoV) by real-time RT-PCR Covid-19 in Critically Ill Patients in the 226 The New England journal of medicine Evidence Supporting Transmission of Severe Acute 229 Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic. Emerging 230 infectious diseases Viral RNA load as determined by cell culture 232 as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Prediction models for diagnosis and 235 prognosis of covid-19 infection: systematic review and critical appraisal